NKMAX CO LTD has a total of 22 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIOPTION AB, VIRXSYS CORP and ORGENESIS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Republic of Korea | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | Singapore | 1 | |
#12 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Park Sang Woo | 15 |
#2 | Rhee Yong-Hee | 12 |
#3 | Jung Jae Seob | 12 |
#4 | Kim Yong Man | 12 |
#5 | Lee Jae Myun | 3 |
#6 | Rhee Yong Hee | 3 |
#7 | Yoon Joo Chun | 3 |
#8 | Kim Jong Sun | 2 |
#9 | Yee Cassian | 2 |
#10 | Kim Tae-Gyun | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019152663A1 | Method of producing natural killer cells and composition for treating cancer | |
EP3746095A1 | Method of producing natural killer cells and composition for treating cancer | |
KR20190093500A | Composition for Anti-cancer Comprising CD56+ Natural Killer Cells | |
KR20190093499A | Manufacturing Method for Natural Killer Cells | |
WO2018118907A1 | Pharmaceutical composition and methods comprising immune cells and ponatinib |